{"id":408670,"date":"2021-01-05T09:32:52","date_gmt":"2021-01-05T14:32:52","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408670"},"modified":"2021-01-05T09:32:52","modified_gmt":"2021-01-05T14:32:52","slug":"paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/","title":{"rendered":"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SANDUSKY, Ohio<\/span>, Jan. 5, 2021<\/span> \/PRNewswire\/ —\u00a0PAO Group, Inc. (USOTC: PAOG) today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts.\u00a0PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward\u00a0initiating an Investigational New Drug application (IND) with the Food and Drug Administration (FDA).\u00a0<\/p>\n

On July 30, 2020<\/span>, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY) RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”<\/p>\n

Veristat, a scientific-minded global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through\u00a0clinical development<\/a>\u00a0to\u00a0regulatory approval<\/a>. With more than 26 years’ experience in clinical trial planning and execution, Veristat is equipped to support any development program.\u00a0<\/p>\n

Learn more about PAOG at www.paogroupinc.com<\/a>.<\/p>\n

Learn more about Veristat at www.veristat.com<\/a>. <\/p>\n

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b<\/span>-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.<\/p>\n

CONTACT INFORMATION<\/p>\n

Contact Us:
Jim DiPrima<\/span>
+1 888-272-6472
info@pao.group<\/a><\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment-301201114.html<\/a><\/p>\n

SOURCE PAO Group, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SANDUSKY, Ohio, Jan. 5, 2021 \/PRNewswire\/ —\u00a0PAO Group, Inc. (USOTC: PAOG) today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts.\u00a0PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward\u00a0initiating an Investigational New Drug application (IND) with the Food and Drug Administration (FDA).\u00a0 On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY) RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.” Veristat, a scientific-minded global clinical research organization (CRO), … <\/p>\n

Continue reading “PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408670","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SANDUSKY, Ohio, Jan. 5, 2021 \/PRNewswire\/ —\u00a0PAO Group, Inc. (USOTC: PAOG) today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts.\u00a0PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward\u00a0initiating an Investigational New Drug application (IND) with the Food and Drug Administration (FDA).\u00a0 On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY) RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.” Veristat, a scientific-minded global clinical research organization (CRO), … Continue reading "PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T14:32:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN37713&sd=2021-01-05\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment\",\"datePublished\":\"2021-01-05T14:32:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/\"},\"wordCount\":352,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN37713&sd=2021-01-05\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/\",\"name\":\"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN37713&sd=2021-01-05\",\"datePublished\":\"2021-01-05T14:32:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN37713&sd=2021-01-05\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN37713&sd=2021-01-05\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/","og_locale":"en_US","og_type":"article","og_title":"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment - Market Newsdesk","og_description":"PR Newswire SANDUSKY, Ohio, Jan. 5, 2021 \/PRNewswire\/ —\u00a0PAO Group, Inc. (USOTC: PAOG) today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts.\u00a0PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward\u00a0initiating an Investigational New Drug application (IND) with the Food and Drug Administration (FDA).\u00a0 On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY) RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.” Veristat, a scientific-minded global clinical research organization (CRO), … Continue reading \"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T14:32:52+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN37713&sd=2021-01-05","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment","datePublished":"2021-01-05T14:32:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/"},"wordCount":352,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN37713&sd=2021-01-05","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/","name":"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN37713&sd=2021-01-05","datePublished":"2021-01-05T14:32:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN37713&sd=2021-01-05","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN37713&sd=2021-01-05"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paog-engages-veristat-for-cro-services-to-advance-cbd-copd-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408670"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408670\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}